Article abstract


Nature Biotechnology 25, 465 - 472 (2007)
Published online: 25 March 2007 | doi:10.1038/nbt1288

An anti-infective peptide that selectively modulates the innate immune response

Monisha G Scott1, Edie Dullaghan1,4, Neeloffer Mookherjee2,4, Natalie Glavas1, Matthew Waldbrook2, Annick Thompson1, Aikun Wang1, Ken Lee1, Silvana Doria2, Pam Hamill2, Jie Jessie Yu2, Yuexin Li2, Oreola Donini1, M Marta Guarna1, B Brett Finlay3, John R North1 & Robert E W Hancock2


We show that an innate defense–regulator peptide (IDR-1) was protective in mouse models of infection with important Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus and Salmonella enterica serovar Typhimurium. When given from 48 h before to 6 h after infection, the peptide was effective by both local and systemic administration. Because protection by IDR-1 was prevented by in vivo depletion of monocytes and macrophages, but not neutrophils or B- and T-lymphocytes, we conclude that monocytes and macrophages are key effector cells. IDR-1 was not directly antimicrobial: gene and protein expression analysis in human and mouse monocytes and macrophages indicated that IDR-1, acting through mitogen-activated protein kinase and other signaling pathways, enhanced the levels of monocyte chemokines while reducing pro-inflammatory cytokine responses. To our knowledge, an innate defense regulator that counters infection by selective modulation of innate immunity without obvious toxicities has not been reported previously.

Top
  1. Inimex Pharmaceuticals Inc., 3650 Wesbrook Mall, Vancouver, British Columbia, Canada V6S 2L2.
  2. Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z4
  3. Michael Smith Laboratories, 2259 Lower Mall Research Station, University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z4.
  4. These authors contributed equally to this work.

Correspondence to: Robert E W Hancock2 e-mail: bob@cmdr.ubc.ca



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Beyond comparison?antibiotics from genome data?

Nature Biotechnology Research News (01 Dec 2001)


Extra navigation

naturejobs

natureproducts


ADVERTISEMENT